Första AP-fonden’s United Therapeutics UTHR Stock Holding History

Första AP-fonden’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,500	Closed	-$4.14M	–	496
2025 Q4	$4.14M	Buy	8,500 +600	+8%	+$279K	0.02%	436
2025 Q3	$3.31M	Buy	7,900 +100	+1%	+$33.6K	0.02%	473
2025 Q2	$2.24M	Sell	7,800 -200	-3%	-$59.8K	0.01%	517
2025 Q1	$2.47M	Sell	8,000 -200	-2%	-$68.5K	0.02%	507
2024 Q4	$2.89M	Hold	8,200	–	–	0.02%	510
2024 Q3	$2.94M	Buy	8,200 +800	+11%	+$270K	0.02%	503
2024 Q2	$2.36M	Sell	7,400 -1,300	-15%	-$344K	0.02%	505
2024 Q1	$2M	Buy	8,700 +1,100	+14%	+$248K	0.02%	540
2023 Q4	$1.67M	Buy	7,600 +5,100	+204%	+$1.18M	0.02%	553
2023 Q3	$565K	Sell	2,500 -5,900	-70%	-$1.36M	0.01%	538
2023 Q2	$1.85M	Buy	+8,400	New	+$1.86M	0.02%	524

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Första AP-fonden's UTHR Position: Q1 2026 in Review

Första AP-fonden sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 8,500 shares — an estimated $4.14M sold.

Första AP-fonden first reported a position in UTHR in Q2 2023 and held it in 11 quarters. The position peaked at $4.14M in Q4 2025. 853 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

Första AP-fonden reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
Första AP-fonden sold 8,500 United Therapeutics shares in Q1 2026, an estimated $4.14M.
Första AP-fonden first reported a position in United Therapeutics in Q2 2023 and held it in 11 quarters.
Första AP-fonden's United Therapeutics position peaked at $4.14M in Q4 2025.
853 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Första AP-fonden's 13F filing for Q1 2026.